Skip to main content
Cancer Questions?

Sarah Cannon Leadership and Physician Experts

Photo of Fred LeMaistre, MD

Fred LeMaistre, MD

Senior Vice President, Market Operations; Physician-in-Chief of Blood Cancers, Sarah Cannon Transplant and Cellular Therapy Network

Dr. LeMaistre joined Sarah Cannon in 2012, and is responsible for the clinical operations of the Sarah Cannon markets and leads the development of the Sarah Cannon Transplant and Cellular Therapy Network. The Transplant and Cellular Therapy Network provides a multidisciplinary approach to standardize blood cancer therapies including blood and marrow transplantation (BMT). Previously the medical director for Texas Institute of Medicine and Surgery, LeMaistre is board certified in internal medicine and medical oncology, and has published more than 200 manuscripts.

He is a founding member and former president of the Foundation for the Accreditation of Cellular Therapy (FACT) and he established the first community-based BMT program in 1993. LeMaistre previously served as the president of the American Society for Blood and Bone Marrow Transplant and is currently a member of the American Society of Hematology. He received his medical degree from Southwestern Medical School in Texas and performed a fellowship in medical oncology at the University of Texas Health Science Center with training in BMT at Fred Hutchinson Cancer Center in Seattle, Wash.